Add like
Add dislike
Add to saved papers

The Role of Killer Immunoglobulin-like Receptor (KIR) Genes in Susceptibility to HIV-1 Infection and Disease Progression: A Meta-analysis.

Genetic studies on the association of the killer immunoglobulin-like receptor (KIR) genes with HIV-1 infection and disease progression have been widely carried out with somewhat contradictory results. Therefore, we undertook a quantitative assessment based on 25 studies [involving 3,216 HIV-1 infected subjects, 1,690 exposed uninfected subjects, 1,262 healthy controls (HCs), 748 typical progressors (TPs), and 244 long-term nonprogressors (LTNPs)] to further define the roles of KIR in HIV-1 control/susceptibility. An overall analysis, showed that, among the 16 KIR genes, the presence of KIR2DS4 may associate with an elevated risk of HIV-1 infection (P < 0.05, using HCs), while KIR3DS1 may associate with a reduced risk (P < 0.001, using HCs). In the subgroup analyses, among Africans, KIR2DS4 also revealed a significant risk of HIV-1 infection (P < 0.05), while KIR2DL2, 2DL5, and 2DS3 conferred a protective role (P < 0.05). KIR2DL2 and 3DL1 showed an increased risk of acquiring infection among Caucasians (P < 0.05). A negative effect on susceptibility to infection for KIR2DL1, 2DL3 and 3DS1 was found among East Asians. 3DS1 conferred a protective effect of HIV-1 infection among serodiscordant couples (P < 0.05). Moreover, among Chinese, KIR2DL3 was significantly lower in frequency in TPs when compared to LTNPs (P < 0.05), indicating a possible role in the delay of disease progression. This meta-analysis supports the individual studies that associate specific KIR genes with HIV-1 infection and disease progression and further emphasises that this outcome differs according to specific populations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app